In addition to activating the STAT3 pathway, xenograft studies have shown that this mechanism is responsible for the induction of a cancer stem cell state in GBM cells (OLIG2, SOX2, and POU3F2 are up-regulated) [162]) leading to higher tumorigenicity and TMZ resistance (Figure 3, Molecular event 28). This evidence concerns the gene STAT3 and cancer.